| Vasotec Dosages & Strengths | ||||
|---|---|---|---|---|
| Strength | Format | Route | Strength | Class |
| Vasotec 5 mg | tablet | oral | 1.0 each | OTC |
| Vasotec 10 mg | tablet | oral | 1.0 each | OTC |
| Vasotec 20 mg | tablet | oral | 1.0 each | OTC |
| Vasotec 2.5 mg | tablet | oral | 1.0 each | OTC |
| Vasotec 1.25 mg/mL | solution | intravenous | 1.0 milliliter(s) | OTC |
Posted by rbrunes 16 days ago
My mother is on vasotec for a little more than a year and ever since she started taking it she has had a sore throat, joints pain and for the past 3 months a daily headache.... i want her to switch to something different and i keep pointing out to her doctor that i think that vasotec is cause this but he doesnt think so since my mother has been taking "enalapril maleate" for years....however that doesnt convince me... what should i do please??? im mostly concerned about her daily headaches.
Posted by ramsuda over 2 years ago
My Dermatologist thinks that the particular condition of my toes that turn pale,sometimes red and sometimes purple. Also they are itchy when the feet are warm but when cold,itchiness and color disappears.
Posted by kim516 over 3 years ago
Can vasotec cause heavy sweating from just the head?
UPDATE 2-Stada raises dividend as 2007 profits rise - Reuters
N: Quote, Profile, Research) Zocor cholesterol and Vasotec hypertension drugs, will publish its final 2007 results on March 27. ...
Thu Mar 06 07:54:40 +0000 2008
UPDATE 2-Stada raises dividend as 2007 profits rise - Reuters
N: Quote, Profile, Research) Zocor cholesterol and Vasotec hypertension drugs, will publish its final 2007 results on March 27. ...
Thu Mar 06 07:54:40 +0000 2008
UPDATE 2-Stada raises dividend as 2007 profits rise - Reuters
N: Quote, Profile, Research) Zocor cholesterol and Vasotec hypertension drugs, will publish its final 2007 results on March 27. ...
Thu Mar 06 07:54:40 +0000 2008
enalapril maleate
enalaprilat - The active metabolite of the pro-drug enalapril, a dicarboxylate-containing angiotensin-converting enzyme (ACE) inhibitor with antihypertensive activity. Enalaprilat prevents the conversion of angiotensin I into angiotensin II by inhibiting ACE, thereby leading to decreased vasopressor activity and resulting in vasodilation. This agent also decreases aldosterone secretion by the adrenal cortex, which leads to an increase in natriuresis.